Sphera Funds Management Ltd. Ac Immune Sa Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $584,521 - $914,903	-121,019 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $750,317 - $1.01 Million	121,019 New	121,019 $812,000
Q1 2019 May 15, 2019	SELL	$3.65 - $11.68 $1.13 Million - $3.63 Million	-310,613 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.35 - $11.7 $1.42 Million - $2.26 Million	-192,950 Reduced 38.32%	310,613 $2.94 Million
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $3.97 Million - $8.28 Million	503,563 New	503,563 $4.03 Million

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $233M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.